HomeCompareTXUG vs JNJ

TXUG vs JNJ: Dividend Comparison 2026

TXUG yields 0.53% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TXUG wins by $390.00 in total portfolio value
10 years
TXUG
TXUG
● Live price
0.53%
Share price
$23.69
Annual div
$0.12
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.4K
Annual income
$54.58
Full TXUG calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — TXUG vs JNJ

📍 TXUG pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTXUGJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TXUG + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TXUG pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TXUG
Annual income on $10K today (after 15% tax)
$44.83/yr
After 10yr DRIP, annual income (after tax)
$46.39/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $657.22/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TXUG + JNJ for your $10,000?

TXUG: 50%JNJ: 50%
100% JNJ50/50100% TXUG
Portfolio after 10yr
$20.2K
Annual income
$441.18/yr
Blended yield
2.18%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

TXUG
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TXUG buys
0
JNJ buys
0
No recent congressional trades found for TXUG or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTXUGJNJ
Forward yield0.53%3.36%
Annual dividend / share$0.12$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$20.4K$20.0K
Annual income after 10y$54.58$827.78
Total dividends collected$537.00$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: TXUG vs JNJ ($10,000, DRIP)

YearTXUG PortfolioTXUG Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,753$52.74$10,676$355.77+$77.00TXUG
2$11,558$53.00$11,407$389.39+$151.00TXUG
3$12,421$53.24$12,198$426.53+$223.00TXUG
4$13,344$53.47$13,056$467.62+$288.00TXUG
5$14,331$53.69$13,987$513.12+$344.00TXUG
6$15,389$53.89$14,998$563.56+$391.00TXUG
7$16,520$54.08$16,098$619.52+$422.00TXUG
8$17,730$54.25$17,295$681.69+$435.00TXUG
9$19,026$54.42$18,599$750.82+$427.00TXUG
10$20,412$54.58$20,022$827.78+$390.00TXUG

TXUG vs JNJ: Complete Analysis 2026

TXUGStock

TXUG is an actively managed fund that aims for long-term capital growth. The investment adviser aims to achieve this by selecting companies of various sizes that exhibit growth characteristics, such as increasing revenues, earnings, and growth potential. The portfolio will typically contain 35-50 issuers and focus on developed markets outside the US. Portfolio selection considers domestic and international economic developments, outlooks for securities markets, interest rates and inflation, the supply and demand for securities, and analysis of specific issuers. To hedge its exposure in any investment into US dollars or other currencies, the fund may use derivative instruments, such as currency forwards.

Full TXUG Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this TXUG vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TXUG vs SCHDTXUG vs JEPITXUG vs OTXUG vs KOTXUG vs MAINTXUG vs ABBVTXUG vs MRKTXUG vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.